|
Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 80 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012" provides data on the Retinitis Pigmentosa (Retinitis) clinical trial scenar.....
Introduction GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012" provides data on the Retinitis Pigmentosa (Retinitis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinitis Pigmentosa (Retinitis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinitis Pigmentosa (Retinitis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 6 Introduction 7 Retinitis Pigmentosa (Retinitis) 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Retinitis Pigmentosa (Retinitis) 24 Subjects Recruited Over a Period of Time 25 Prominent Sponsors 26 Top Companies Participating in Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials 28 Prominent Drug Comparison 30 Clinical Trial Profiles 31 Clinical Trial Overview of Top Companies 31 Neurotech Pharmaceuticals, Inc. 31 Clinical Trial Overview of Neurotech Pharmaceuticals, Inc. 31 R-Tech Ueno, Ltd. 32 Clinical Trial Overview of R-Tech Ueno, Ltd. 32 Okuvision GmbH 33 Clinical Trial Overview of Okuvision GmbH 33 Sucampo Pharmaceuticals, Inc. 34 Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 34 Pfizer Inc. 35 Clinical Trial Overview of Pfizer Inc. 35 Daewoong Pharmaceutical Co., Ltd. 36 Clinical Trial Overview of Daewoong Pharmaceutical Co., Ltd. 36 Oxford BioMedica plc 37 Clinical Trial Overview of Oxford BioMedica plc 37 Isis Pharmaceuticals, Inc. 38 Clinical Trial Overview of Isis Pharmaceuticals, Inc. 38 Allergan, Inc. 39 Clinical Trial Overview of Allergan, Inc. 39 Johnson & Johnson 40 Clinical Trial Overview of Johnson & Johnson 40 Clinical Trial Overview of Top Universities / Institutes / Hospitals 41 National Neurovision Research Institute 41 Clinical Trial Overview of National Neurovision Research Institute 41 Third Military Medical University 42 Clinical Trial Overview of Third Military Medical University 42 Kyushu University 43 Clinical Trial Overview of Kyushu University 43 Chiba University Hospital 44 Clinical Trial Overview of Chiba University Hospital 44 Nagoya City University Hospital 45 Clinical Trial Overview of Nagoya City University Hospital 45 Institute of Biomedical Research and Innovation Hospital 46 Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital 46 Montpellier University Hospital 47 Clinical Trial Overview of Montpellier University Hospital 47 Azienda Policlinico Umberto I 48 Clinical Trial Overview of Azienda Policlinico Umberto I 48 Tokyo Women's Medical University 49 Clinical Trial Overview of Tokyo Women's Medical University 49 Tehran University of Medical Sciences 50 Clinical Trial Overview of Tehran University of Medical Sciences 50 Semmelweis University 51 Clinical Trial Overview of Semmelweis University 51 Chiba University 52 Clinical Trial Overview of Chiba University 52 Osaka University 53 Clinical Trial Overview of Osaka University 53 Indian Council of Medical Research 54 Clinical Trial Overview of Indian Council of Medical Research 54 Seoul National University Hospital 55 Clinical Trial Overview of Seoul National University Hospital 55 Columbia University 56 Clinical Trial Overview of Columbia University 56 University of Sao Paulo 57 Clinical Trial Overview of University of Sao Paulo 57 Sheba Medical Center 58 Clinical Trial Overview of Sheba Medical Center 58 Johns Hopkins University 59 Clinical Trial Overview of Johns Hopkins University 59 University of California, San Francisco 60 Clinical Trial Overview of University of California, San Francisco 60 Five Key Clinical Profiles 61 Appendix 77 Abbreviations 77 Definitions 77 Research Methodology 78 Secondary Research 78 About GlobalData 79 Contact Us 79 Disclaimer 79 Source 80 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, G7 Countries, 2012* 17 Retinitis Pigmentosa (Retinitis) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, E7 Countries, 2012* 19 Retinitis Pigmentosa (Retinitis) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotech Pharmaceuticals, Inc., 2012* 31 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by R-Tech Ueno, Ltd., 2012* 32 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Okuvision GmbH, 2012* 33 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2012* 34 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 35 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Pharmaceutical Co., Ltd., 2012* 36 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxford BioMedica plc, 2012* 37 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2012* 38 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012* 39 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 40 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Neurovision Research Institute, 2012* 41 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2012* 42 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012* 43 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2012* 44 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University Hospital, 2012* 45 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2012* 46 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2012* 47 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Policlinico Umberto I, 2012* 48 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2012* 49 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2012* 50 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Semmelweis University, 2012* 51 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2012* 52 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2012* 53 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2012* 54 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 55 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012* 56 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 57 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012* 58 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 59 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 60 List of Figures Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Retinitis Pigmentosa (Retinitis) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Retinitis Pigmentosa (Retinitis) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28 Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30 GlobalData Methodology 78 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
